Podcasts about hiv research

This week, Jonathan welcomes Mark Connors to explore the advancements in HIV vaccine technology and the progress in global understanding of HIV since the 1980s, highlighting how these insights can inform approaches to other viruses. Use the following timestamps to navigate this episode:  (00:00)-Introduction (01:28)-Mark's perfect menu (03:23)-Choosing immunology and HIV research (05:30)-HIV in the early 80s (07:50)-T cell responses in controlling HIV (13:45)- HIV history lesson (20:50)-Merging our understanding of HIV with cancer immunotherapy (23:12)-Challenges and breakthroughs in HIV vaccine development (27:20)-T cell mechanisms at the sub-cellular level – the key to immunotherapies? (29:25)-Immune responses to other viruses (31:32)-Origin of HIV (33:28)-Mark's three wishes for healthcare  

What Robert F. Kennedy's confirmation as HHS secretary could mean for global health | CNN

What do we think of this blatant propaganda?

In today's episode, we are honored to be joined by Leor Weinberger, the William and Ute Bowes Distinguished Professor of Virology, director of the Gladstone Center for Cell Circuitry, professor of pharmaceutical chemistry, and professor of biochemistry and biophysics at Gladstone Institutes/University of California, San Francisco. As a world-renowned virologist and quantitative biologist, Leor has made a significant impact in the field of HIV research with his groundbreaking discovery of the HIV virus latency circuit. Leor's lab studies the fundamental processes of viral biology in the pursuit of developing innovative first-in-class therapies against HIV. They use computational and experimental approaches, including quantitative, single-cell and single-molecule microscopy and mathematical modeling… Click play to find out:  How quantitative and theoretical biophysics apply to HIV. Why HIV latency has always been a problem with successful treatment.  What happens when viral loads are lower in the blood of infected individuals.  When to administer a therapeutic that overcomes barriers to biodistribution.  How are Leor and his team tackling the biggest challenges in human health? Tune in now to learn more about their unique and innovative approach to disrupting the way science is done – and how these discoveries have the potential to change lives! You can follow along with Leor and his fascinating work with the Gladstone Center for Cell Circuitry here. Episode also available on Apple Podcast: http://apple.co/30PvU9

Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, are the recipients of the 2024 Lasker-Bloomberg Public Service Award for their decades of work on AIDS in Africa. The infectious diseases epidemiologists recently reflected on their life's work in a conversation with JAMA Deputy Editor and infectious diseases physician Preeti Malani, MD, MSJ. Related Content: Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award AIDS in Africa—Impact of Research

In this episode, Colleen F. Kelley, MD, MPH, and Jemma Samitpol discuss key considerations to improve the patient experience among transgender persons with HIV, including: Unique circumstances faced by transgender people trying to access HIV care (eg, stigma, discrimination)Best practices to improve access and linkage to HIV careWays to integrate gender-affirming care into HIV careCreating a welcoming and inclusive environmentOffering same-day HIV treatmentAddressing potential drug–drug interactions with gender-affirming hormone therapy (GAHT), including ART and natural remediesUnderstanding and communicating expectations of GAHT (eg, treatment response, timing of effects)Providing information on the safety of gender-affirming surgeriesImportance of providing person-centered care (eg, mental health, substance abuse, housing, harm reduction)Strategies on how to promote a gender-affirming environment (eg, wearing pronoun buttons, staff training)Consequences to the lack of gender recognition lawsHow to “be an ally” for transgender people with HIVPresentersColleen F. Kelley, MD, MPHProfessor of MedicineDivision of Infectious DiseasesDepartment of MedicineCo-Director, Emory Center for AIDS ResearchAssociated Dean for Research, Emory at GradyEmory University School of MedicineAtlanta, GeorgiaKritima Jemma SamitpolTangerine Clinic SupervisorInstitute of HIV Research and InnovationBangkok, ThailandGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast channel on Apple Podcasts, Google Podcasts, or Spotify.

Discover the latest breakthroughs in brain-computer interface technology as Synchron enables mind control of Apple's Vision Pro headset. This groundbreaking development allows individuals with severe paralysis to interact with advanced devices using only their thoughts, marking a significant advancement in accessibility technology. Learn how Synchron's minimally invasive approach differs from competitors like Neuralink and explore the potential impact on the lives of those with motor impairments.Dive into the world of AI as OpenAI rolls out its Advanced Voice Mode for ChatGPT, featuring real-time conversations, emotional tone detection, and new preset voices. Uncover the controversy surrounding the removal of the "Sky" voice and the company's plans for future rollouts. Plus, get a sneak peek at the upcoming Friend AI Necklace, a wearable device powered by Anthropic AI's Claude 3.5 language model, set to revolutionize AI companionship and assistance.Explore cutting-edge scientific advancements, including a promising new weapon against HIV using llama nanobodies. Discover how these unique antibodies offer unprecedented neutralization capabilities against a wide range of HIV strains, potentially leading to more effective, longer-lasting treatments. Stay informed about the latest developments in technology, science, and accessibility as we unpack the stories shaping our future.From Perplexity's Discover feed:https://www.perplexity.ai/page/openai-begins-hyper-realistic-2_y7h8vPQEWaM4g63WvnVAhttps://www.perplexity.ai/page/friend-s-ai-necklace-hEQy.RkzTMyU0E1wn1eYNwhttps://www.perplexity.ai/page/hybrid-human-llama-antibody-fi-UCs.nTMFTu6QaRoOTXp0gAhttps://www.perplexity.ai/page/synchron-s-vision-pro-mind-con-3ZW3W7OnT5qY0fhTpwGDnwPerplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin

In this episode The Wistar Institute's podcast, we take a deep dive with Dr. Luis Montaner, one of Wistar's longest-serving scientists. Listen today as he discusses his lab's groundbreaking HIV cure research and how he decided to dedicate his life to the cause of searching for an HIV cure.

If you have a subscription to Spotify, you can now hear this audiobook on Anthony Fauci for free.  

December is World AIDS Month, so we're bringing back Dr. Celeste Watkins-Hayes to learn about recent developments in HIV research. We're also covering weight-neutral health care, a win for the LGBTQIA+ community, and a rare bird spotting in Colombia! Celeste Watkins-Hayes is the Jean E. Fairfax Collegiate Professor of Public Policy and Sociology at the University of Michigan's Gerald R. Ford School of Public Policy and founding director of the school's Center for Racial Justice. Dr. Watkins-Hayes holds a PhD and MA in sociology from Harvard University and a BA from Spelman College. You can follow Dr. Celeste Watkins-Hayes on Instagram @celestewatkinshayes and on Twitter @watkinshayes. You can learn more about her work here. Check out her previous episode of Getting Curious here. You can follow the Ford School on Instagram @fordschool. For more information on the news stories we covered this week, head to @curiouswithjvn on Instagram. Jonathan is on Instagram @JVN. Transcripts for each episode are available at JonathanVanNess.com. Find books from Getting Curious, Curious Now, and Pretty Curious guests at bookshop.org/shop/curiouswithjvn. Our senior producers are Chris McClure and Julia Melfi. Our associate producer is Allison Weiss. Our engineer is Nathanael McClure. Our theme music is also composed by Nathanael McClure. Production support from Julie Carrillo, Anne Currie, and Chad Hall. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode 1 - 40 Years Later: Looking Back at the Beginning of the HIV/AIDS EpidemicIn this episode of Going anti-Viral, we revisit a panel discussion titled "40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic," sponsored by the IAS–USA. Dr Gerald Friedland moderates a panel of key medical figures who served at the frontlines of the HIV/AIDS epidemic during its early years. The panel, consisting of Dr Kathryn Anastos, Dr Donna Futterman, Dr Sheldon Landesman, and Dr Fred Valentine discusses their experiences, the systemic responses, and the stigma associated with the disease. They contemplate on how the lessons learned from HIV are relevant to the current COVID-19 pandemic and the potential pandemics that may come in the future.The discussion took place on June 13, 2022, at the Scott M. Hammer Annual Update on HIV Management in New York City.00:00 Introduction and Overview of the Podcast00:37 Panel Discussion: Reflecting on the Early Days of the HIV Epidemic01:20 Panelists Share Their Personal Experiences and Challenges02:29 The Impact of HIV on Medical Professionals and Their Careers03:01 The Spread of HIV in Different New York City Boroughs03:45 Panelists' Current Roles and Their Initial Encounters with HIV06:01 The Struggle with Internalized Homophobia in HIV Patients06:26 The Evolution of HIV Treatment and the Reaction of Medical Providers07:44 The Emotional Impact of the HIV Epidemic20:06 The Challenges of Creating a System of Care for HIV Patients21:23 The Stigma and Misunderstandings Surrounding HIV40:29 The Role of Activism in the Fight Against HIV41:35 Institutional Responses to the HIV Epidemic43:21 Challenges in Pediatric Care for HIV Patients44:10 Stigma and Discrimination in Healthcare44:47 International Efforts in HIV Testing47:01 Safety Measures in HIV Research Labs48:43 Health and Hospitals Corporation's Role in HIV Care50:01 The Impact of HIV on Medical Education and Training54:11 The Role of Activism in the HIV/AIDS Response55:40 Lessons from HIV for Future Pandemics57:16 The Response of the Medical Community to HIV58:21 The Importance of Addressing Social Determinants of Health01:00:08 The Future of HIV Research and Care01:06:34 Closing Remarks and Reflections__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

People who are pregnant or lactating (PLP) have historically been excluded from research because of concerns for the developing fetus. But this has led to a dearth of data on new interventions against health threats for this population. In the case of HIV, pregnancy raises the risk of acquiring HIV by up to three times, but providers often do not have the data to know whether a new intervention is safe or how it will work for pregnant patients. As a result, PLP and their physicians are left to make difficult decisions around the use of proven HIV prevention products as they await more data specific to pregnancy and lactation.  But change is in the air. Champions for the inclusion of PLP in research are paving the way for a paradigm shift— one that will redefine this population from needing protection from research to being better protected through research. In this episode of Px Pulse, AVAC's Manju Chatani-Gada takes us through conversations with a trial participant who became pregnant, researchers, policy-makers, and donors to understand why this population gets excluded, the impact it has, and what to do about it.

In this episode, speak with a national leader within the PA profession, Dr. Carl Garrubba, about his unique path to becoming a PA, his involvement and leadership in PAEA, HIV research and its impact on future infectious disease frameworks, and his PA program development. This episode is sponsored by Exam Master.   The PA Path Podcast is produced by Association Briefings.

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/boghuma_kabisen_titanji_ethical_riddles_in_hiv_research ■Post on this topic (You can get FREE learning materials!) https://englist.me/145-academic-words-reference-from-boghuma-kabisen-titanji-ethical-riddles-in-hiv-research-ted-talk/ ■Youtube Video https://youtu.be/ChsozjgpWLo (All Words) https://youtu.be/qaAM63fnQV8 (Advanced Words) https://youtu.be/M_z_v2SVTZg (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

This Podcast features Dr Jakkrapatara Boonruang (Dr Fair), who is a research physician at Thailand's Institute of HIV Research and Innovation (IHRI). He shares insights about gender affirming hormonal therapy for transgender people, barriers to its access, and recommendations on how to scale it up with inclusion, rights, ethics, people-centric approaches, and science.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.ThanksCNS team

African HIV research now makes up almost a third of total research being conducted into the virus. A new study highlights how it has increased from just 5 per cent in 1986. But there's still a way to go until the quantity of research reflects the burden of HIV infections on the African continent. Claudia Hammond speaks to Professor Thumbi Ndung'u and Dr Omolara Baiyegunhi from the Africa Health Research Institute in South Africa about the future of research being conducted in Africa by Africans and why it matters. Non-alcoholic fatty liver disease is now the fastest growing liver disease in Europe. It already affects 38 per cent of people around the world. We hear from Vienna in Austria where a mobile clinic is offering people liver scans, and specialists have been teaching school children about liver health. Dr Ann Robinson joins Claudia in the studio to discuss the latest health research including a US study with good news for people diagnosed early with a skin cancer known as melanoma. And a simple reason why staying up late might mean you won't live as long as someone who enjoys an early start to the day. And who better to crunch the data on siestas than the President of the Spanish Federation of Sleep Medicine Societies. Dr Carlos Egea explains how the modern siesta is more about taking a short time to relax, rather than a long afternoon sleep. Presenter: Claudia Hammond Producer: Clare Salisbury Production Coordinator: Jonathan Harris Image credit: Credit:Portra Creative #:675577867

This podcast features Dr Nittaya Phanuphak, Executive Director of IHRI (Institute of HIV Research and Innovation) who got twice elected to the Governing Council of International AIDS Society (IAS) from Asia Pacific region, and currently serves on the GC IAS too. She explains in details how community-led interventions that were instrumental in improving access to thousands of people to #PreExposureProphylaxis #PrEP and #PostExposureProphylaxis #PEP, are threatened and disrupted due to recent Government decisions. These recent government decisions also impact access to free HIV testing for all or condoms and other HIV prevention services. Now several groups like APCOM, IHRI, Raks Thai Foundation, Swing Foundation, Rainbow Sky Association of Thailand, FHI 360, MPlus Foundation Chiang Mai, among others are lobbying the Thai government to reverse this policy guideline, and resume and scale up access to HIV prevention and whole range of services which is key to be on track to #endAIDS by 2030. Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.ThanksCNS team

The development of COVID-19 vaccines has allowed some people to return to “normal life”. But even now, not everyone can access these vaccines, particularly people living in low-income countries.  Unequal access to healthcare is a sadly familiar story for people living with HIV. From 1997 to 2006, an estimated 12 million people on the continent of Africa died because HIV treatment was too expensive.  In this episode of HIV unmuted, the award-winning IAS podcast, we will discuss why these parallels in unfair healthcare access are showing up time and time again, look ahead to the recent monkeypox outbreak, and assess whether we have learnt the critical lessons from COVID-19 and HIV.  Our guests are: Patricia Asero Ochieng is the chairperson of the International Community of Women Living with HIV in Kenya. She was diagnosed with HIV in the 1990s when her daughter was born. In Kenya at the time, access to HIV treatment was scarce and stigma was rampant. Patricia knew the answer lay in access and began advocating for treatment.  Eric Goemaere is an infectious disease specialist with a career spanning 40 years with Médecins Sans Frontières. When Eric arrived in South Africa in the mid-1990s, he was ready for a challenge, working on the biggest HIV epidemic in the world. Little did he expect the greater challenges of access to HIV treatment he was about to face. Meg Doherty is the Director of the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes at the World Health Organization (WHO). Meg helps us to understand why – even when we have the science and means to deal with outbreaks – we continue to have unequal outcomes in global health.  Mike Ryan is the Executive Director for the WHO Health Emergencies Programme. Being at the forefront of managing acute risks to global health for nearly 25 years, Mike discusses pandemic preparedness and access issues in global health and applies this to the current outbreak.   Rena Janamnuaysook is a Program Manager for Transgender Health at the Institute of HIV Research in Bangkok, Thailand, where she established the Tangerine Community Health Clinic, the first trans-led health clinic in Southeast Asia. When COVID-19 hit, she had to pivot at the local level to address the issues that globally continue to hamper our pandemic responses.  If you are listening to this episode before 29 July 2022 and want to learn more about the intersection of HIV, COVID-19, and monkeypox, along with the latest scientific breakthroughs in the HIV response, attend the 24th International AIDS Conference (AIDS 2022) virtually or in-person in Montreal.

A new study shows racial and ethnic disparities in the treatment of patients with opioid use disorder worsened during the COVID-19 pandemic, and an IU School of Nursing researcher is working to improve HIV research in teens and young adults.

This week, we're interviewing our very own Dr Julian Hoad!Julian began his life, as most Hoads do, in Kent. As a child, he was an army brat and lived in many different places (although mostly in and around London). Like most vets, he knew from a very young age that he wanted to be a vet.He eventually arrived at Plymouth Polytechnic where he studied Biological Sciences, Microbiology and Biochemistry. His career took a sudden turn when he found out that he was unable to apply for vet school, and instead turned his sights to a career in Virology after accepting a job at an HIV research lab. Later on, he re-applied to become a vet at the Royal Veterinary College and talks a bit about how he managed to fund the degree through various grants and kind donations.Julian is also an accomplished actor and has had a great deal of experience on stage. In his teenage years, Julian was offered a potentially career-making role in a film - but turned down the opportunity to continue his A-Levels so that he could become a vet. He still takes part regularly in theatre productions, despite it being a surprisingly dangerous hobby!Support the show

Today, in episode 457, our expert Infectious Disease and Community Medicine doctors discuss the latest on COVID-19. We talk about how Israel is considering a herd immunity strategy as outbreaks intensify, and some consequential benefits of HIV research. As always, join us for all the COVID-19 information you need, explained in clear terms by health experts. Website: NoiseFilter - Complex health topics explained simply (noisefiltershow.com) Animations: NoiseFilter - YouTube Instagram: NoiseFilter (@noisefiltershow) • Instagram photos and videos Facebook: NoiseFilter Show | Facebook TikTok: https://www.tiktok.com/@noisefiltershow --- Send in a voice message: https://anchor.fm/noisefilter/message

Learn about why mRNA vaccines are older than you think; and the scientific theories about why animals have white bellies.  mRNA vaccines are older than you think by Grant Currin  Dolgin, E. (2021). The tangled history of mRNA vaccines. Nature, 597(7876), 318–324. https://doi.org/10.1038/d41586-021-02483-w  ‌Lewis, T. (2021, September 15). An mRNA Pioneer Discusses How Her Work Led to the COVID Vaccines. Scientific American. https://www.scientificamerican.com/article/an-mrna-pioneer-discusses-how-her-work-led-to-the-COVID-vaccines/  ‌Harvard University. (2021). How mRNA vaccines work [YouTube Video]. In YouTube. https://www.youtube.com/watch?v=TbaCxIJ_VP4  Why do so many animals have white bellies? Here are the theories by Cameron Duke  Exhibit Galleries Blog. (2016). Neaq.org. http://galleries.neaq.org/2014/09/countershading-camouflage.html Harris, J., & Olivier Penacchio. (2015, October 7). Sunscreen or camouflage? Why so many animals have dark backs and pale bellies. The Conversation. https://theconversation.com/sunscreen-or-camouflage-why-so-many-animals-have-dark-backs-and-pale-bellies-48603 Penacchio, O., Cuthill, I. C., Lovell, P. G., Ruxton, G. D., & Harris, J. M. (2015). Orientation to the sun by animals and its interaction with crypsis. Functional Ecology, 29(9), 1165–1177. https://doi.org/10.1111/1365-2435.12481 Penacchio, O., Lovell, P. G., Cuthill, I. C., Ruxton, G. D., & Harris, J. M. (2015). Three-Dimensional Camouflage: Exploiting Photons to Conceal Form. The American Naturalist, 186(4), 553–563. https://doi.org/10.1086/682570 Follow Curiosity Daily on your favorite podcast app to learn something new every day withCody Gough andAshley Hamer. Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. See omnystudio.com/listener for privacy information.

Welcome back to the show! A K.L.P Entertainment Broadcast station-News Station-over 43 International Countries. Now Streaming and broadcast on Spotify,Apple Podcast,ITunes, Podcast Addict. The new hit radio station that focuses on everything K.L.P Entertainment, Swanky Studios, and Grizzly Talk Podcast. with the collaboration of news such as entertainment, Films, Music, Video Games, and media. Integrated our listeners in Atlanta.

Welcome back to the show! A K.L.P Entertainment Broadcast station-News Station-over 43 International Countries. Now Streaming and broadcast on Spotify,Apple Podcast,ITunes, Podcast Addict. The new hit radio station that focuses on everything K.L.P Entertainment, Swanky Studios, and Grizzly Talk Podcast. with the collaboration of news such as entertainment, Films, Music, Video Games, and media. Integrated our listeners in Atlanta.

In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.Presenter:Chloe Orkin, MBChB, FRCP, MDProfessor of HIV  Queen Mary University of LondonConsultant Physician  Lead for HIV Research  Barts Health NHS TrustThe Royal London HospitalLondon, United KingdomContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3eUPAj9 

Here in the US we have been fighting the Covid virus for a year with some progress over the last months. However our community was decimated by another scourge  the HIV epidemic. Although we have perfected the so called “cocktail” medicines that force the HIV to sequester in the body rendering a death sentence to be a chronic […]

In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention strategies.  Presenter:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  DirectorDesmond Tutu HIV CentrePast PresidentInternational AIDS SocietyFaculty of Health SciencesUniversity of Cape TownCape Town, South AfricaContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3s41GtM 

Global health epidemiologist Angela Kaida joins Below the Radar to share her passion for research to support the sexual and reproductive health of women and nonbinary people. An associate professor in SFU’s Faculty of Health Sciences and a recent researcher-in-residence with SFU’s Community-Engaged Research Initiative, Angela adopts an interdisciplinary, community-driven, ethics-based approach to researching the health of people living with HIV. In this episode, Angela is in conversation with Am Johal about the process and potentials of embracing a community-engaged approach in her research, from community outreach and the training of peer research associates, to issues around informed consent. She discusses some of her recent projects, including the Life and Love with HIV platform and the CHIWOS-PAW project, and shares how she and her colleagues have had to adjust to working with the communities they serve in the context of COVID-19. Resources: — About Angela Kaida: https://www.sfu.ca/fhs/about/people/profiles/angela-kaida.html — “3 Questions with Researcher-in-Residence Dr. Angela Kaida” on the CERi blog: https://www.sfu.ca/ceri/blog/2020/meet-researcher-in-residence-angela-kaida.html — Life and Love with HIV: https://www.lifeandlovewithhiv.ca/ — Canadian HIV Women's Sexual and Reproductive Health Cohort Study—Positive Aboriginal Women (CHIWOS-PAW): http://www.chiwos.ca — SFU’s Community-Engaged Research Initiative: https://www.sfu.ca/ceri.html

In this episode, we discuss the evolution of the HIV/AIDS epidemic with a focus on how the virus disproportionately impacts the Black community in the United States. Despite only making up 12% of the population, Black Americans account for 42% of new HIV diagnoses and 44% of HIV-related deaths. Bryan Baugh, Global Medical Affairs Leader of Infectious Diseases and Vaccines at Janssen, and Greg Millett, Vice President and Director of Public Policy at amfAR, explore the factors that contribute to this inequality, what can be done about it, and the importance of diversity in HIV research and beyond.

What does the black death, HIV, and Covid-19 have in common? This week we're looking into the past, teasing apart the surprising similarities and learnings from previous pandemics - HIV/ AIDS in the 1980s and the Black Death in the 14th century. Join Vivienne Parry as she speaks with Dr John Sabapathy (Senior Lecturer in Medieval History), Prof Graham Hart (Professor of Sexual Health and HIV Research), Prof Dame Anne Johnson (Professor of Infectious Disease).Access the transcript and more information here: www.ucl.ac.uk/ucl-minds/podcasts…avirus-whole-story See acast.com/privacy for privacy and opt-out information.

Dr. Gabriel Culbert is an Assistant Professor in the College of Nursing at the University of Illinois Chicago and Dr. Agung Waluyo is the Directorate of Community Engagement & Empowerment at the Universitas Indonesia. Gabe and Agung describe how they met in Jakarta in 2003 and how their research partnership has developed since then. Agung reflects on what it was like to learn about drug use and the HIV epidemic after a sheltered childhood, recalls being warned that he could be sent to jail for doing stigma research focused on Indonesian healthcare providers, and shares how he navigates conversations about politically sensitive research with government officials. Gabe describes the reasons why the HIV epidemic became concentrated in prisons in Indonesia, questions why Indonesia has one of the highest HIV mortality rates despite having the largest universal healthcare system in the world, and envisions an expanded role for nurses in HIV prevention and treatment. Valerie and Carly nominate Gabe and Agung to be poster children for international research partnerships. Read more about Agung's work here: http://staff.ui.ac.id/agungwssRead more about Gabe's work here: https://nursing.uic.edu/profiles/gabriel-culbert/

My guest is Zakithi Mkhize from South Africa. In this episode, we find out that she had a dream of being a medical doctor that did not work out as planned. However, life led her to still pursue an academic career in medicine. Currently, she is a PhD Candidate in Medicine (Virology) at the HIV Pathogenesis Program at the University of KwaZulu-Natal in Durban, South Africa. Her research focuses on a particular gene called the transactivator of transcription (Tat), which enhances HIV replication and its interaction with host transcription factor positive transcription elongation factor b (P-TEFB). She studies how genetic variation in Tat can affect its interaction with P-TEFB, efficient transcription, and latency. Latency is a significant barrier to HIV cure. Thus, her research will inform HIV cure studies. Zakithi also has a YouTube channel called ‘BlackGirlScientist'. The channel is geared toward motivating, encouraging & inspiring young black people, especially black women, to get into science. She shares her journey through science as well as knowledge & expertise. She aims to break stereotypes and make science cool. Lastly, we also talk about the #CelebratingYouthinSTEM #BlackInSTEMSA campaign that we are running in collaboration with The Root of the Science Podcasts. The importance of this campaign during South Africa's Youth Month. Stay tuned.Twitter: @Zakkie_MInstagram: @Zakkie_M & @blackgirl.scientistLinkedIn: Zakithi MkhizeBuzzsprout - Let's get your podcast launched! Start for FREEDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show (https://paypal.me/RootofSciPod?locale.x=en_US)

While giving can feel good, it doesn’t always impact those that need your donation the most. Today’s guest is Anya Marchenko, a research assistant at Berkeley’s Center for Effective Global Action with a passion for development economics. Anya joins us to talk about effective altruism, a powerful approach that uses evidence and reason to figure out how to benefit others as much as possible, and taking action on that basis. In our conversation, Anya breaks down the science of giving by explaining that there are different types of donating and why donating to international causes that deal with chronic problems results in the most impact. Anya explores the theory that guides development economics and effective altruism while highlighting how these cash transfers respect the agency of the people these interventions aim to help. After sharing with us the practical skills from her discipline that can benefit you in life, Anya talks about how thinking about competitive advantage can help you make better decisions about where you can do more good. Anya shares her transformative experiences of conducting field research in Kenya and how she got to see the impact of giving first-hand. Finally, Anya talks about COVID-19 silver-linings and how it’s changing the perception of giving. In this episode, Anya gives us clear examples of how small donations can do a massive amount of good in the world. Tune in at one of the links below to learn more!Listen on SpotifyListen on Google PodcastsListen on Apple PodcastsKey Points From This Episode:The different types of donations and which donations make the most impactAnya describes four different ways people donate. First, there can be local donations vs. non-local/international. Within these two categories, people can either donate to address an acute problem like an emergency relief fund, or donating to address a chronic problem such as donating to criminal justice reform, global poverty, or HIV Research.Why direct cash transfers are often the best form of donationsAnya and many other development economists argue that direct cash transfers are the best use of donations in terms of doing the most good for people in need. People know for themselves what their most immediate needs are, and research has shown that money given with no strings attached can significantly improve peoples’ day-to-day lives, often more cheaply and effectively than other forms of giving.How to find organizations that are worth donating toWhen donating money, Anya recommends charity evaluators like GiveWell, which has researchers look into the efficacy of the organizations you are looking to donate to. Another option is Animal Charity Evaluators. If you are going to do the research for yourself, try to figure out what the actual activity of the charity is, read research on the intervention or think pieces by sources like Vox or the NY Times, check if their financial information is transparent, and check who is funding them. All of these factors will help you determine where your dollar will have the most impact.How to make decisions based on comparative advantageThe economic principle of comparative advantage helps make decisions like what product is more effectively produced in what country. This can be applied to everyday life decisions too.

What can be learned from past pandemics to help us prepare for the future? Science Festival Chair Vivienne Parry is joined by John Sabapathy, Senior Lecturer in Medieval History, Nicola Miller, Professor of Latin-American History, Graham Hart, Professor of Sexual Health and HIV Research and Professor of Infectious Disease, Anne Johnson.

Dr. Carmen Logie is the Canada Research Chair in Global Health Equity and Social Justice with Marginalized Populations at the University of Toronto. Valerie and Carly talk with her about partnering with communities globally on HIV research. Carmen pushes back on research that paints LGBT people as “sad and risky”, advises that we “only get what we ask for” in our work, and grapples with telling stories that document structural oppression while also highlighting individual agency and resilience. Valerie and Carly vow to get fluevogs before their next professional presentations. Read more about Carmen's work here: https://socialwork.utoronto.ca/profiles/carmen-logie/Watch Carmen's Ted Talk here: https://www.youtube.com/watch?v=HOkBN8C-4pcFollow Carmen's podcast here: https://www.buzzsprout.com/1024792

What does the black death, HIV, and Covid-19 have in common? This week we're looking into the past, teasing apart the surprising similarities and learnings from previous pandemics - HIV/ AIDS in the 1980s and the Black Death in the 14th century. Join Vivienne Parry as she speaks with Dr John Sabapathy (Senior Lecturer in Medieval History), Prof Graham Hart (Professor of Sexual Health and HIV Research), Prof Dame Anne Johnson (Professor of Infectious Disease) Access the transcript and more information here: www.ucl.ac.uk/ucl-minds/podcasts…avirus-whole-story

Welcome to Finance and Fury, the Furious Friday edition. Always told to listen to the experts – argument by authority – The experts know what is best for you – Also – the higher authority in your life – the government – knows what is best for you Now - You aren’t allowed to gather at home with more than 10 people – have to socially distance in public or face a $1,000 fine – due to a central power telling you so Interesting thing with experts and higher authorities – we only ever hear from one side – the side that works in with the Governments narrative   Today – want to share What are other experts saying? We have to believe all experts after all - There are plenty of Other experts – who have differing opinions Dr Joel Kettner- former Chief Public Health Officer for Manitoba province (Canada between Saskatchewan and Ontario) and Medical Director of the International Centre for Infectious Diseases – must be worried right? What he says: I have never seen anything like this, anything anywhere near like this. – Sounds bad right? I’m not talking about the pandemic, because I’ve seen 30 of them, one every year. It is called influenza. And other respiratory illness viruses, we don’t always know what they are. But I’ve never seen this reaction, and I’m trying to understand why. I worry about the message to the public, about the fear of coming into contact with people, being in the same space as people, shaking their hands, having meetings with people. I worry about many, many consequences related to that. In the province of Hubei, where there has been the most cases and deaths by far, the actual number of cases reported is 1 per 1000 people and the actual rate of deaths reported is 1 per 20,000. So maybe that would help to put things into perspective. But it might be very deadly – or infectious – Dr Sucharit Bhakdiis a specialist in microbiology - head of the Institute for Medical Microbiology and Hygiene and one of the most cited research scientists in German history What he says: We are afraid that 1 million infections with the new virus will lead to 30 deaths per day over the next 100 days. But we do not realise that 20, 30, 40 or 100 patients positive for normal coronaviruses are already dying every day. [The government’s anti-COVID19 measures] are grotesque, absurd and very dangerous. The life expectancy of millions is being shortened. The horrifying impact on the world economy threatens the existence of countless people. The consequences on medical care are profound. Already services to patients in need are reduced, operations cancelled, practices empty, hospital personnel dwindling. All this will impact profoundly on our whole society. All these measures are leading to self-destruction and collective suicide based on nothing but a spook. What about Italy? Dr Yoram Lassis an Israeli physician, politician and former Director General of the Health Ministry. He also worked as Associate Dean of the Tel Aviv University Medical School and during the 1980s presented the science-based television show Tatzpit. What he says:Italy is known for its enormous morbidity in respiratory problems, more than three times any other European country. In the US about 40,000 people die in a regular flu season and so far 40-50 people have died of the coronavirus, most of them in a nursing home in Kirkland, Washington. In every country, more people die from regular flu compared with those who die from the coronavirus.…there is a very good example that we all forget: the swine flu in 2009. That was a virus that reached the world from Mexico and until today there is no vaccination against it. But what? At that time there was no Facebook or there maybe was but it was still in its infancy. The coronavirus, in contrast, is a virus with public relations. Whoever thinks that governments end viruses is wrong.   So why are scientists referring to it as COVID19 - Dr Wolfgang Wodargis a German physician specialising in Pulmonology, politician and former chairman of the Parliamentary Assembly of the Council of Europe. In 2009 he called for an inquiry into alleged conflicts of interest surrounding the EU response to the Swine Flu pandemic – where some members of their board represented the companies producing the vaccines What he says: Politicians are being courted by scientists…scientists who want to be important to get money for their institutions. Scientists who just swim along in the mainstream and want their part of it […] And what is missing right now is a rational way of looking at things. We should be asking questions like “How did you find out this virus was dangerous?”, “How was it before?”, “Didn’t we have the same thing last year?”, “Is it even something new?” That’s missing. What are we spooked of – Covid19 – how did this get its naming – COronaVIrus Disease 2019. From the director-general of the WHO: “Coronavirus” refers to the family of viruses that the disease belongs to and is named for its crown-like shapes under a microscope - “corona” comes from the latin word for “crown” – then 2019 is the year In naming - “We had to find a name that did not refer to a geographical location, an animal, an individual, or a group of people, and which is also pronounceable and related to the disease,” But what is the name given to it within the medical community: SARS-CoV-2 Coronavirus Study Group of the International Committee on Taxonomy of Viruses - pathogen is “a sister to severe acute respiratory syndrome coronaviruses,” hence the “SARS” in the name But the WHO is already pushing back on using the name SARS-CoV-2 for the virus - “From a risk communications perspective, using the name SARS can have unintended consequences in terms of creating unnecessary fear for some populations. For that reason and others, in public communications WHO will refer by using: ‘the virus responsible for COVID-19’ or ‘the COVID-19 virus,’ but neither of these designations is intended as replacements for the official name of the virus.” - Which has SARS at the front – or as scientists call it SARS – 2 - It is essentially SARS 1 and SARS 2 - Hendrik Streeckis a German HIV researcher, epidemiologist and clinical trialist. He is professor of virology, and the director of the Institute of Virology and HIV Research, at Bonn University. What he says: The new pathogen is not that dangerous, it is even less dangerous than Sars-1. The special thing is that Sars-CoV-2 replicates in the upper throat area and is therefore much more infectious because the virus jumps from throat to throat, so to speak. But that is also an advantage: Because Sars-1 replicates in the deep lungs, it is not so infectious, but it definitely gets on the lungs, which makes it more dangerous. You also have to take into account that the Sars-CoV-2 deaths in Germany were exclusively old people. In Heinsberg, for example, a 78-year-old man with previous illnesses died of heart failure, and that without Sars-2 lung involvement. Since he was infected, he naturally appears in the Covid 19 statistics. But the question is whether he would not have died anyway, even without Sars-2. So it is branding – they don’t want to say it is just another form of SARSs – But even Taking what we are being told at face value- it is a new deadly type of coronavirus – Like SARS, MERS or what was a fictional disease (CAPS) use in a ‘war games’ scenario called Event201 –   I like to read and research events – and found some interesting works by a few groups – based around hypothetical scenarios of a virus outbreak – similar to war games, or model UN projects play out – Occurred in October 2019 – Event 201 simulates an outbreak of a novel zoonotic coronavirus transmitted from bats to pigs to people that eventually becomes efficiently transmissible from person to person, leading to a severe pandemic. The pathogen and the disease it causes are modeled largely on SARS, but it is more transmissible in the community setting by people with mild symptoms. Event 201 – A global pandemic exercise - CAPS Pandemic  - Official Statement - Selected moments from the Event 201 pandemic tabletop exercise hosted by The Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation on October 18, 2019, in New York, NY. The exercise illustrated the pandemic preparedness efforts needed to diminish the large-scale economic and societal consequences of a severe pandemic. Going back further - Operation Lock Step – The Rockefeller Foundation 2010 Report Title - “Scenarios for the Future of Technology and InternationalDevelopment- Covers a scenario called “LOCK STEP: A world of tighter top-down government control and more authoritarian leadership, with limited innovation and growing citizen pushback.” This about most countries in the world – more government top down control – not much happening with the economy – innovation was being stifled – lots of protests and civil unrest – yellow vests – France and EU – protests in Hungary over shutting their borders, Wuhan over environment, HK over instilling their own rulers – lots of unrest – Similar to where the world was just 3 months ago Scenario - “the pandemic that the world had been anticipating for years finally hit. Unlike 2009’s H1N1, this new influenza strain — originating from wild geese — was extremely virulent and deadly. Even the most pandemic-prepared nations were quickly overwhelmed when the virus streaked around the world, infecting nearly 20 percent of the global population and killing 8 million in just seven months…The pandemic also had a deadly effect on economies: international mobility of both people and goods screeched to a halt, debilitating industries like tourism and breaking global supply chains. Even locally, normally bustling shops and office buildings sat empty for months, devoid of both employees and customers.” This sounds eerily familiar. Then the scenario gets very interesting: “During the pandemic, national leaders around the world flexed their authority and imposed airtight rules and restrictions, from the mandatory wearing of face masks to body-temperature checks at the entries to communal spaces like train stations and supermarkets. Even after the pandemic faded, this more authoritarian control and oversight of citizens and their activities stuck and even intensified. In order to protect themselves from the spread of increasingly global problems — from pandemics and transnational terrorism to environmental crises and rising poverty — leaders around the world took a firmer grip on power.” What was this scenario – one of panic and fear – if enough panic and fear can be forced onto populations – the more they will allow their own freedoms to be reduced for safety Safety over freedom - Fear is never a good guide to sound reason. Many people would gladly surrender some of their liberties, in exchange for peace and stability. This is what the game-plan is all about. How much liberty will people give up? Too much hype and limited facts; the conclusion is that there is 99% fear, and 1% facts. The main stream media are scant with information. Experts opinion on the subject - Dr Peter Goetzscheis Professor of Clinical Research Design and Analysis at the University of Copenhagen and founder of the Cochrane Medical Collaboration. He has written several books on corruption in the field of medicine and the influence of big pharmaceutical companies. What he says: Our main problem is that no one will ever get in trouble for measures that are too draconian. They will only get in trouble if they do too little. So, our politicians and those working with public health do much more than they should do. No such draconian measures were applied during the 2009 influenza pandemic, and they obviously cannot be applied every winter, which is all year round, as it is always winter somewhere. We cannot close down the whole world permanently. Should it turn out that the epidemic wanes before long, there will be a queue of people wanting to take credit for this. And we can be damned sure draconian measures will be applied again next time. But remember the joke about tigers. “Why do you blow the horn?” “To keep the tigers away.” “But there are no tigers here.” “There you see!” – Simpsons did this with a rock - I find these Hypothetical scenarios very accurate to how events have played out – if nobody had tuned into the news last few weeks – and hadn’t talked to anyone – wouldn’t know anything is going on beyond Government announcement to policy changes – living off grid that isn’t reliant on the system Thought of something very interesting – None of us have a say – Government does the measures – nobody asked if we would like to keep our jobs – they are deemed a hazard and cancelled – The Gov officials still get to keep their jobs – in QLD we are still being forced to go vote this Sat – using social distancing which will be enforced though – for our protection of course – same pencil   The question remains – why would any government destroy the freedoms of the people it is meant to protect – but instead we are treated like children with no say – but in this case the kids are paying the adults – similar to child celebrity parents – didn’t end out so well for calkin – Psychological effects of this – everyone becomes afraid of each other – told to socially distance – other people are the carries and the threat – don’t be close to communities you can rely on – isolate – sperate – fear other people and trust us to protect you Social snitching – where we are turned against one another – dobbing in those having people over = house parties or going outside – similar to Stalin, Mao’s and NKs populations – use social shame as a way for people to self police Based around the normalisation of these measures – what stops this occurring any flu season or the outbreak of a virus – flu season basically lasts all year due to the seasons – if the experts say we need to – people may be likely to follow Thank you for listening to today's episode. If you want to get in contact you can do so here: http://financeandfury.com.au/contact/   Links: Rockefeller Report - http://www.nommeraadio.ee/meedia/pdf/RRS/Rockefeller%20Foundation.pdf Event 201 - https://www.youtube.com/watch?v=AoLw-Q8X174 Experts say - https://www.zerohedge.com/geopolitical/12-experts-question-covid-19-panic

Part three of a four part series of recordings from LaTrobe University’s Australian Research Centre in Sex, Health and Society’s one-day symposium looking critically at the intersection points of HIV and people’s lives, especially people and communities affected by HIV who have not been at the centre of the Australian HIV response. Hear from Dr Jennifer Power, Research Fellow at the Australian Research Centre in Sex, Health and Society and Kirsty Machon, CEO of Positive Women Victoria discussing intersectionality and evidence in HIV research. 

In this podcast, Mr I discusses two recently published articles about HIV therapy. CD4 T lymphocytes are known to act as viral reservoirs in those on antiretroviral therapy, but could the use of metabolic activity inhibitors help to destroy them? Equally, could the inflammatory marker GlycA indicate a greater risk of atherosclerosis in HIV patients?

The Last Gift study aims to understand where and how HIV hides in the human body when a person with HIV is taking HIV medications. The Last Gift study tackles these aims by studying people with HIV who are terminally ill from a disease other than HIV, like cancer, ALS, or heart disease. The study follows these volunteers with regular blood draws before the person dies and then examines multiple tissues throughout their bodies after death. From these samples, investigators hope to understand how HIV remains hidden from both the person’s immune system and from current HIV therapy. Results from these studies are designed to help develop ways to clear these reservoirs with future therapies. Dr. Davey Smith, Professor of Medicine and Chief of Infectious Diseases and Global Public Health at UCSD discusses the study and its medical and ethical implications. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Show ID: 32991]

The Last Gift study aims to understand where and how HIV hides in the human body when a person with HIV is taking HIV medications. The Last Gift study tackles these aims by studying people with HIV who are terminally ill from a disease other than HIV, like cancer, ALS, or heart disease. The study follows these volunteers with regular blood draws before the person dies and then examines multiple tissues throughout their bodies after death. From these samples, investigators hope to understand how HIV remains hidden from both the person’s immune system and from current HIV therapy. Results from these studies are designed to help develop ways to clear these reservoirs with future therapies. Dr. Davey Smith, Professor of Medicine and Chief of Infectious Diseases and Global Public Health at UCSD discusses the study and its medical and ethical implications. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Show ID: 32991]

December 1st is World AIDS Day. HIV AIDS affects 35 million people worldwide, and although the number of new infections is slowly decreasing, last year it still caused one million deaths. The virus, HIV, attacks the body's immune system by infecting white blood cells, also called "lymphocytes". Lewis Thomson has been finding out what the future holds for treatment, and what it's like to be diagnosed with the virus, and met with Professor Andrew Lever from the University of Cambridge, who researches the virus. Like this podcast? Please help us by supporting the Naked Scientists

December 1st is World AIDS Day. HIV AIDS affects 35 million people worldwide, and although the number of new infections is slowly decreasing, last year it still caused one million deaths. The virus, HIV, attacks the body's immune system by infecting white blood cells, also called "lymphocytes". Lewis Thomson has been finding out what the future holds for treatment, and what it's like to be diagnosed with the virus, and met with Professor Andrew Lever from the University of Cambridge, who researches the virus. Like this podcast? Please help us by supporting the Naked Scientists

With 1.1 million Americans already living with HIV and another 40,000 new cases every year, Carolina researchers have been working to hone treatments and find a cure for the virus for decades. Through partnerships with pharmaceutical and collaborations with units across campus, the University's HIV researchers are getting closer to discovering a cure. In this week's episode, we're talking about Carolina HIV research and the next step toward a cure with Nancie Archin, an assistant professor of medicine at the UNC School of Medicine.

Katti Horng's path to studying HIV in the combined DVM/PhD degree at UC Davis began with a Chinese tradition for babies: infants are presented with objects symbolizing different professions to see what their futures will hold. PhDivas Xine and Liz talk to Katti about cow rectums, animal rights vs. animal welfare, and the difference between the cultures of professional and graduate degrees. We get a new perspective on sexism: even though women are now the majority in veterinary medicine, we learn that the gender gap is not so easily overcome. What does interdisciplinary medical research look like? Katti and Liz talk about the unexpected connections between their research on HIV, cancer, and chronic inflammation. More on Katti Horng's research: http://www.vetmed.ucdavis.edu/whatsnew/article.cfm?id=3631

The University of North Carolina at Chapel Hill is home to some of the world’s best HIV research. Numerous teams of researchers are tirelessly investigating the virus, which infects nearly 37 million people around the world. One of the those projects, led by Jenna Bone Honeycutt, has recently made to a key discovery that could change the way treatments target the virus. In this week’s episode, we’re talking about the recent findings with Honeycutt, a postdoctoral research fellow with the UNC School of Medicine.

Today’s episode is part 2 of the report from the Australasian HIV Medical Conference – ASHM 2016.  If you missed part 1, you can check it out at insideHIV.net or download it from itunes.On the AFAO community stage, a special symposium featured many of the most exciting developments happening, for positive people.Launching Australia’s first national campaign specifically designed to improve the lives of positive people was Aaron Cogle, CEO of the National Association of People with HIV Australia (NAPWHA).  Aaron explains the evolution of the Good Quality Of Life campaign.NAPWHA also played a part in the development of a world first.  MyLife+ is a smart phone app that helps positive people manage their health and wellbeing. Oonagh Rocks, Community Affairs Manager at ViiV Healthcare details the development of the app, before introducing Bill Patterson, NAPWHA’s Operations Manager. Bill highlights the importance of integrating the lived experience of positive people into something as technologically advanced as the MyLife+ app.This symposium was where insideHIV.net and this podcast series for positive people, launched. Caleb Hawk, the Communications Coordinator of the Victorian AIDS Council, provides some background before Dean Beck launches the project.We also discover the difficulty Doctors have in defining the relationships of men who have sex with men (MSM).  Dr Vincent Cornelisse from Melbourne sexual Health Centre reveals some fascinating findings from his research. 

In the past several decades, HIV has gone from being a death sentence to a virus manageable with medications. With the University of North Carolina at Chapel Hill becoming a hub for HIV research, Carolina's labs have helped push that progress along. In this week's episode, we're talking about Carolina's HIV research with Mike Cohen, Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology, and the director of the Institute for Global Health and Infectious Diseases.

Jonathan sits down with Physician Assistant and PrEP Research Clinician Kayla McLaughlin to talk about what PrEP is, how far HIV research has gotten since the 1980s, and why HIV is so hard to cure. Plus, Kayla discusses the curious cases of the Mississippi Baby and the Berlin Patient.  Find out what today's guest and former guests are up to by following us on Instagram and Twitter @CuriousWithJVN.  Transcripts for each episode are available at JonathanVanNess.com. Check out Getting Curious merch at PodSwag.com. Listen to more music from Quiñ by heading over to TheQuinCat.com. Jonathan is on Instagram and Twitter @JVN and @Jonathan.Vanness on Facebook.

Show-818-Marijuana and Alcohol Increase Risk For Unsafe Sex Marijuana and alcohol use both lead to unique sexual effects and somewhat risky sexual behavior according to a new study.. In the study, published this week in the Archives of Sexual Behavior by researchers affiliated with New York University's Center for Drug Use and HIV Research, researchers talked to adults about their sexual experiences while stoned and while drunk. Plus: -A study on marijuana vs. booze on sex. -Chris Olson from Portland's Indo Expo this weekend -Bree Whitehead from Stoned Media Group and Stoned Girls -Analyzing Gary Johnson's Town Hall Performance

New York HIV Research Centers Consortium 2012 Scientific Conference

Cath Mercer, an associate editor with STI, asks Lisa Langhaug (Centre for Sexual Health and HIV Research, London, UK) about her work investigating the best way to ask Zimbabwean youth about their sexual health.Read the article online: http://tinyurl.com/9wbsegt

Professor Graham Hart (Director of the UCL Centre for Sexual Health and HIV Research, UCL STI editorial board member) talks to Dr Stefan Baral (Center for Public Health and Human Rights, Johns Hopkins) about his research into bisexual concurrency, bisexual partnerships, and HIV among Southern African men who have sex with men.

Perry N Halkitis, Ph.D., M.S. is Professor of Applied Psychology, Public Health, and Medicine, Director of the Center for Health, Identity, Behavior & Prevention Studies, and Associate Dean at New York University. He is also an affiliate of the Center for AIDS Research and Center for Drug Use and HIV Research also at NYU. Dr. Halkitis is highly recognized for his work examining the intersection between the HIV, drug abuse, and mental health in LGBT populations, and is well known as one of the nation?s leading experts on substance use and HIV behavioral research. He is lead editor of two volumes: HIV + Sex: The Psychological and Interpersonal Dynamics of HIV-seropositive Gay and Bisexual Men's Relationships. (American Psychological Association, 2005), and Barebacking: Psychosocial and Public Health Perspectives (2006, Haworth Press). His book, Methamphetamine Addiction: Biological Foundations, Psychological Factors, And Social Consequences was published in 2009, and he is currently working on a new manuscript examining the life experiences of gay men who are long-term survivors of HIV/AIDS, The AIDS Generation (Oxford University Press). Author of over 130 peer-reviewed academic manuscripts, Dr. Halkitis? research has been funded by the National Institutes of Health, and Centers for Disease Control and Prevention, among others. Dr. Halkitis serves on the Committee on Psychology and AIDS of the American Psychological Association (APA), is a member of the Advisory Committee on HIV and STD Prevention and Treatment of the Centers for Disease Control and Prevention (CDC) and Health Services Research Administration (HRSA), as well as the National Institutes of Health (NIH) College of CSR Reviewers. He is the recipient of numerous awards from both professional and community-based organizations, and is an elected a fellow of The New York Academy of Medicine, The Society of Behavioral Medicine, and the American Psychological Association. Dr. Halkitis received his PhD in 1995 from the Graduate Center of the City University of New York, and in 2012 will earn his MPH in the field of epidemiology.

Over the past 15 years, the number of people who die of AIDS each year in the United States has dropped by 70 percent. But AIDS remains a serious public health crisis among low-income African-Americans, particularly women. And in sub-Saharan Africa, the virus killed more than 1.6 million people in 2007. QUEST meets two Bay Area research groups studying innovative approaches that could lead to new treatments and possibly a cure.

A companion to "HIV Research: Beyond the Vaccine"

In this edition of CIRAcast, Leif Mitchell, Assistant Director of CIRA's Community Research Core, speaks with Drs. Nathan Smith and Nathan Hansen on what led these two young scientists to HIV research and what keeps them motivated.

Over the past 15 years, the number of people who die of AIDS each year in the United States has dropped by 70 percent. But AIDS remains a serious public health crisis among low-income African-Americans, particularly women. And in sub-Saharan Africa, the virus killed more than 1.6 million people in 2007. QUEST meets two Bay Area research groups studying innovative approaches that could lead to new treatments and possibly a cure.

Guest: Charles van der Horst, MD Host: Shira Johnson, MD Host Dr. Shira Johnson speaks with Dr. Charles van der Horst about his upbringings as an HIV/AIDS specialist and the directions of HIV research today. Dr van der Horst has been involved in HIV research for 27 years and speaks on his concerns within this field along with current trends and funding in 2008. He also talks about his important work in Malawi and South Africa designing and implementing clinical trials for HIV treatment and prevention.

Host: Maurice Pickard, MD Guest: Mardge Cohen, MD Women in the United States who have contracted HIV are more open in coming forward to seek care and building a network of support than in years previous. Yet the various personal ways in which these patients originally contracted HIV presents a wide array of issues and stresses which physicians must address concurrent to providing good medical care. Dr. Mardge Cohen, Director of Women's HIV Research and founder of the Women and Children HIV program at Stroger Hospital in Chicago, discusses methods to address these challenges with patients. Hosted by Dr. Maurice Pickard.